2025-02-22 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Report

**0. Key Figures & Initial Analysis:**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a range of health benefits programs, including health insurance and related services.

* **Cumulative Return (UNH):** 114.0975
* **Cumulative Return (VOO):** 118.3114
* **Return Difference (UNH vs VOO):** -4.22 (UNH underperformed VOO by 4.22 percentage points)


**1. Performance Comparison & Alpha/Beta Analysis:**

UNH's cumulative return lags behind the S&P 500 (VOO) by approximately 4.22 percentage points, based on the provided data.  The provided relative divergence metric suggests this underperformance is at the lower end of historical fluctuations.

The Alpha/Beta analysis reveals:

* **High CAGR:**  Consistently high Compound Annual Growth Rates (CAGR) ranging from 32% to 102% across the analyzed periods, indicating strong historical growth.
* **Variable MDD:** Maximum Drawdowns (MDD) fluctuate significantly, reflecting periods of substantial volatility.  Note the extremely high MDD of -100% in the 2023-2025 period. This is likely an error in the data and needs clarification.
* **Positive Alpha:** A positive Alpha consistently above 0.1 indicates the stock has historically outperformed its benchmark after accounting for market risk.
* **High Beta:**  A Beta consistently above 0.1 (and generally around 0.3) suggests UNH is more volatile than the overall market.

**2. Recent Price Movement:**

* **Closing Price:** $466.42
* **Previous Close:** $502.42
* **5-Day Moving Average:** $500.82
* **20-Day Moving Average:** $528.26
* **60-Day Moving Average:** $534.12

The stock price is currently trading significantly below its 5, 20, and 60-day moving averages, indicating a clear downtrend.  The recent price drop of approximately $7.17 (from $502.42 to $466.42) represents a notable, but not exceptionally sharp, decline.

**3. Technical Indicators & Expected Return:**

* **RSI (20.61):**  Deeply oversold territory, suggesting potential for a rebound.
* **PPO (-1.19):** Negative PPO indicates bearish momentum.
* **Relative Divergence:** -18.7%, indicating a significant downward shift in relative performance recently.
* **Expected Return (8477.6%):** This extraordinarily high figure requires further investigation.  It seems likely to be an error or a misinterpretation of the data. The provided context doesn't clarify the calculation method. This figure should not be considered a realistic projection.


**4. Recent Earnings Analysis:**

| Date       | EPS     | Revenue          |
|------------|---------|-----------------|
| 2024-11-04 | 6.56    | $100.82 B       |
| 2024-08-09 | 4.58    | $98.86 B        |
| 2024-05-09 | -1.53   | $99.80 B        |
| 2023-11-06 | 6.31    | $92.36 B        |
| 2024-11-04 | 6.31    | $92.36 B        | *(Duplicate entry, likely an error)*


There's a noticeable fluctuation in EPS, including a significant negative EPS in Q2 2024. Revenue remains relatively stable but high, although there is no obvious upward trend. The duplicate entry needs clarification.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue    | Profit Margin |
|---------|------------|---------------|
| 2024-09-30 | $99.18B   | 21.56%        |
| 2024-06-30 | $97.86B   | 21.52%        |
| 2024-03-31 | $98.78B   | 22.26%        |
| 2023-12-31 | $93.25B   | 22.33%        |
| 2023-09-30 | $91.36B   | 24.51%        |

Revenue is relatively consistent with a slight upward trend. Profit margins have generally remained stable but show a slight dip in recent quarters.


**Capital and Profitability:**

| Quarter | Equity     | ROE     |
|---------|------------|---------|
| 2024-09-30 | $94.53B   | 6.41%   |
| 2024-06-30 | $89.36B   | 4.72%   |
| 2024-03-31 | $86.69B   | -1.63%  |
| 2023-12-31 | $88.76B   | 6.15%   |
| 2023-09-30 | $84.49B   | 6.91%   |

Equity has shown growth, but ROE fluctuates, notably showing a negative value in Q1 2024, reflecting the negative EPS during that quarter.


**6. Overall Analysis:**

UNH shows a history of strong growth (high CAGR) but also significant volatility (high Beta and variable MDD).  Recent performance has lagged the S&P 500, and the current price is below key moving averages, suggesting a downtrend.  Technical indicators show oversold conditions, hinting at potential for a price rebound. However, the negative PPO and large recent negative relative divergence are bearish signals.  The recent earnings show some volatility, with a notable negative EPS in one quarter.  Given the inconsistencies in the provided data, particularly the extremely high expected return and -100% MDD,  further investigation and verification of the data are necessary before drawing definitive conclusions.  The data suggests a need for cautious consideration, particularly regarding the validity of the provided "Expected Return."  Professional financial advice should be sought before making any investment decisions.
